Trust Company of Vermont’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $578K | Sell |
2,304
-99
| -4% | -$26.3K | 0.02% | 246 |
|
|
2025
Q3 | $690K | Sell |
2,403
-51
| -2% | -$13.7K | 0.03% | 226 |
|
|
2025
Q2 | $644K | Sell |
2,454
-11
| -0.4% | -$2.68K | 0.03% | 224 |
|
|
2025
Q1 | $574K | Hold |
2,465
| – | – | 0.03% | 223 |
|
|
2024
Q4 | $565K | Sell |
2,465
-86
| -3% | -$19.7K | 0.03% | 233 |
|
|
2024
Q3 | $570K | Sell |
2,551
-2,113
| -45% | -$464K | 0.03% | 222 |
|
|
2024
Q2 | $949K | Sell |
4,664
-597
| -11% | -$121K | 0.05% | 180 |
|
|
2024
Q1 | $1.15M | Buy |
5,261
+848
| +19% | +$187K | 0.06% | 170 |
|
|
2023
Q4 | $1M | Buy |
4,413
+1,393
| +46% | +$293K | 0.07% | 167 |
|
|
2023
Q3 | $607K | Sell |
3,020
-1,267
| -30% | -$267K | 0.04% | 201 |
|
|
2023
Q2 | $889K | Sell |
4,287
-292
| -6% | -$56.6K | 0.06% | 186 |
|
|
2023
Q1 | $903K | Sell |
4,579
-260
| -5% | -$53.5K | 0.06% | 185 |
|
|
2022
Q4 | $979K | Buy |
4,839
+857
| +22% | +$167K | 0.07% | 179 |
|
|
2022
Q3 | $701K | Buy |
3,982
+656
| +20% | +$134K | 0.06% | 185 |
|
|
2022
Q2 | $670K | Buy |
3,326
+486
| +17% | +$104K | 0.05% | 193 |
|
|
2022
Q1 | $643K | Buy |
2,840
+4
| +0.1% | +$941 | 0.04% | 205 |
|
|
2021
Q4 | $765K | Buy |
2,836
+12
| +0.4% | +$2.97K | 0.05% | 194 |
|
|
2021
Q3 | $683K | Buy |
2,824
+204
| +8% | +$51.4K | 0.05% | 195 |
|
|
2021
Q2 | $621K | Buy |
2,620
+87
| +3% | +$19.8K | 0.04% | 208 |
|
|
2021
Q1 | $555K | Hold |
2,533
| – | – | 0.04% | 211 |
|
|
2020
Q4 | $443K | Hold |
2,533
| – | – | 0.04% | 218 |
|
|
2020
Q3 | $410K | Buy |
2,533
+103
| +4% | +$16.3K | 0.04% | 216 |
|
|
2020
Q2 | $347K | Hold |
2,430
| – | – | 0.03% | 222 |
|
|
2020
Q1 | $264K | Sell |
2,430
-48
| -2% | -$6.92K | 0.02% | 247 |
|
|
2019
Q4 | $360K | Hold |
2,478
| – | – | 0.03% | 252 |
|
|
2019
Q3 | $358K | Sell |
2,478
-175
| -7% | -$25.5K | 0.03% | 251 |
|
|
2019
Q2 | $394K | Buy |
2,653
+466
| +21% | +$65K | 0.03% | 244 |
|
|
2019
Q1 | $287K | Buy |
2,187
+70
| +3% | +$8.62K | 0.02% | 263 |
|
|
2018
Q4 | $230K | Sell |
2,117
-403
| -16% | -$54K | 0.02% | 277 |
|
|
2018
Q3 | $376K | Hold |
2,520
| – | – | 0.03% | 250 |
|
|
2018
Q2 | $389K | Buy |
2,520
+114
| +5% | +$17.2K | 0.03% | 245 |
|
|
2018
Q1 | $335K | Hold |
2,406
| – | – | 0.03% | 260 |
|
|
2017
Q4 | $330K | Buy |
2,406
+5
| +0.2% | +$661 | 0.03% | 262 |
|
|
2017
Q3 | $311K | Hold |
2,401
| – | – | 0.03% | 266 |
|
|
2017
Q2 | $318K | Hold |
2,401
| – | – | 0.03% | 270 |
|
|
2017
Q1 | $296K | Hold |
2,401
| – | – | 0.03% | 271 |
|
|
2016
Q4 | $265K | Hold |
2,401
| – | – | 0.03% | 278 |
|
|
2016
Q3 | $284K | Buy |
2,401
+1,949
| +431% | +$230K | 0.04% | 230 |
|
|
2016
Q2 | $51K | Hold |
452
| – | – | 0.01% | 388 |
|
|
2016
Q1 | $45K | Hold |
452
| – | – | 0.01% | 403 |
|
|
2015
Q4 | $48K | Hold |
452
| – | – | 0.01% | 399 |
|
|
2015
Q3 | $42K | Hold |
452
| – | – | 0.01% | 424 |
|
|
2015
Q2 | $47K | Buy |
452
+103
| +30% | +$10.7K | 0.01% | 410 |
|
|
2015
Q1 | $38K | Hold |
349
| – | – | 0.01% | 437 |
|
|
2014
Q4 | $32K | Hold |
349
| – | – | ﹤0.01% | 470 |
|
|
2014
Q3 | $31K | Hold |
349
| – | – | ﹤0.01% | 473 |
|
|
2014
Q2 | $31K | Sell |
349
-146
| -29% | -$12.6K | ﹤0.01% | 453 |
|
|
2014
Q1 | $42K | Buy |
495
+349
| +239% | +$27.8K | 0.01% | 393 |
|
|
2013
Q4 | $11K | Hold |
146
| – | – | ﹤0.01% | 580 |
|
|
2013
Q3 | $12K | Sell |
146
-46
| -24% | -$3.87K | ﹤0.01% | 555 |
|
|
2013
Q2 | $17K | Buy |
+192
| New | +$15.9K | ﹤0.01% | 492 |
|
Other funds holding LH
Trust Company of Vermont's LH Position: Q4 2025 in Review
Trust Company of Vermont reduced its Labcorp (LH) stake by 4.1% in Q4 2025, selling an estimated $26.3K and leaving 2,304 shares worth $578K. The position accounts for 0.02% of the portfolio, ranked #246.
Trust Company of Vermont first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.15M in Q1 2024. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.
- Trust Company of Vermont held 2,304 shares of Labcorp worth $578K as of Q4 2025.
- Trust Company of Vermont sold 99 Labcorp shares in Q4 2025, an estimated $26.3K.
- Labcorp made up 0.02% of Trust Company of Vermont's portfolio in Q4 2025, its #246 holding.
- Trust Company of Vermont first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
- Trust Company of Vermont's Labcorp position peaked at $1.15M in Q1 2024.
- 1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.